FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a topical preparation for contaminated wound healing. The above preparation contains lidocaine hydrochloride 0.1-0.2%, thrombolysin 30-36%, metronidazole 0.25-0.5%, clindamycin 0.3-0.45%, rifampicine 0.45-0.6%, olive oil 10%, sea buckthorn oil 1.5-2.0%, starch 5.1% and silver water.
EFFECT: invention promotes reducing contaminated wound complications, provides the advance of antibacterial active substances through intertissue spaces to the deep tissues with faster pathogenic flora inhibition in a wide range.
2 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF BITE WOUNDS TREATMENT | 2015 |
|
RU2597767C2 |
| OINTMENT FOR TREATING BITTEN WOUNDS | 2011 |
|
RU2473329C2 |
| COMPOSITION FOR POSTOPERATIVE PREVENTION OF PURULENT COMPLICATIONS OF BONE AND SOFT-TISSUE STRUCTURES WHEN USING EXTERNAL FIXATION PIN-AND-FRAME APPARATUS, DEVICE FOR POSTOPERATIVE WOUND SANITATION | 2021 |
|
RU2770402C1 |
| MEDICAL OINTMENT | 2010 |
|
RU2442565C1 |
| METHOD OF TREATING SUBCUTANEOUS HEMATOMA FORMED BY ANIMAL BITE | 2009 |
|
RU2417765C2 |
| AGENT FOR WOUNDS, BURNS AND INFECTIOUS INFLAMMATORY DISEASES OF SKIN, APPENDAGES AND MUCOUS MEMBRANES | 2010 |
|
RU2452475C2 |
| THERAPEUTIC AGENT | 2010 |
|
RU2429818C1 |
| METHOD FOR SIMULATING BITE WOUND | 2013 |
|
RU2548820C2 |
| COMPOUNDS FOR TREATING CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES | 2011 |
|
RU2575477C2 |
| PHARMACEUTICAL COMPOSITION SUITABLE FOR INTRAVAGINAL DELIVERY | 2021 |
|
RU2828262C1 |
